Cargando…
Immune Protection of Stem Cell-Derived Islet Cell Therapy for Treating Diabetes
Insulin injection is currently the main therapy for type 1 diabetes (T1D) or late stage of severe type 2 diabetes (T2D). Human pancreatic islet transplantation confers a significant improvement in glycemic control and prevents life-threatening severe hypoglycemia in T1D patients. However, the shorta...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382875/ https://www.ncbi.nlm.nih.gov/pubmed/34447354 http://dx.doi.org/10.3389/fendo.2021.716625 |